This is a snippet of the transcript, sign up to read more.
In the hospital, the hardwired setup is confusing. They have the Masimo SafetyNet and Patient SafetyNet, but the hardwired SafetyNet in the hospital is much preferred. You're limited there from a market perspective and trying to sell to hospitals. Masimo is up against the same thing as many other technologies, in that many hospitals have old infrastructure; you need services, data closets, switches, and wiring in the rooms. You have to shut down rooms to do construction, so any technology vendors working inside the hospital's walls will be up against that challenge. That might be a limitation to hospital systems adopting them. And from a remote perspective, remote patient monitoring is still pretty new in healthcare terms.
This is a snippet of the transcript, sign up to read more.
I think there are some valid points there. Certainly, the convenience factor would be huge from a patient compliance perspective. If you're looking at short-term, like 30 days, whatever, you will run into the question of what's the cost to the hardware? Is this going to be a hospital-owned thing that we try to reacquire when a patient has improved, and what does that look like from the support, maintenance, privacy perspective, and all the logistics behind that versus, is it a somewhat affordable, disposable, probably a rather expensive disposable, but is that going to be the strategy they recommend? Versus do we have this digital health hub through our hospital where you're with your primary care doctor, and they need you to get a blood pressure cuff? Here's the website; this is the blood pressure cuff we recommend. Or you've got COPD now, or your asthma is getting really bad; we think you should buy this watch.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research